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Single cell suspensions of murine epidermal cells were stud-
ied for the generation ofl eukotrienes (LTs) , using in vitro 
bioassays for chemotaxis , reverse-phase high-pressure li-
quid chrom atogra phy (HPLC), and radioimmunoassays 
(RIAs). A combination of arachidonic acid (AA) at 10 - 3- 10 - 4 
M with the calciul11 ionophore A 23187 at 5 X 10 - 6 M w as 
the most potent stimulus, causing release of L Ts w ithin 
10-30 min . Other stimuli, like the N-formyl-methionyl-
leucyl-phenylalanine, at 10 - 7 M and bradykinin at 10 - 3 M . 
were less effective, and the tumor promotor phorbol-myr-
istate-acetate (10 - 5- 10 - 8 M) ca used no release at alL AA 
induced release at cy totoxic concentrations, but the o ther 
stimuli did no t, and keratinocytes frol11 different body re-
, Recently, mu ch interest was fO. cused on the potential 
role of leukotrienes (LTs) in a number of inflamma-
to ry processes, parti cul arly in cutaneous diseases [1). 
Amo ng these med iators, L TB4 and s lig htl y less so., 
its metabo lite 20-0 H-L TB4 , are potent chemotactic 
facto rs for a variety of cells, including neut rophil s, eos inophils, 
mon ocytes, and fibrob lasts [2-6). LTB" has been demonstrated 
in a variety of inflammatory processes [7], including psoriasis, 
atopic eczema , and bullous pemphigoid [8-11) . 
T he bes t studied cell type that secretes L Ts in vitro is the 
neutrophil of human or animal sources [1) . Stimuli that induce 
LT release from this cell include bo th the ca lcium iono phore A 
23187 (Ion) and the chemotacti c N-fo rm yl-peptides, alone or in 
the presence o f arichidonic acid (AA) [1 2, 13]. Other cell sources 
of these mediato rs are eosinophils, mast cell s, and l11.ono-
cytes/macrophages [1 , 14,15]. Keratinocytes are also able to gen-
era te L Ts, as has been shown for subcellular prepa rations of mu-
rine cells and for intact human keratinocytes [11 ,16-18]. 
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Abbreviations: 
AA: arachidonic acid 
BOC: N-t-BOC-L-norlellcyl-L-Iellcyl-L-phenylalaninc 
HETE: hydroxyeicosatctraenoic acid 
HPLC: high-pressurc liquid chromatography 
Ion: ionophorc 
L T: lcukotricne 
NDGA: nordihydroguaretic acid 
NFMLP: n-form yl-methionyl-lcllcyl-phenylalaninc 
PMA: phorbol-myristatc-acetate 
PG: prostaglandin 
RIA: radioimmunoassay 
g ions were equally good sources of the L Ts. In vivo o r in 
vitro pretreatment ofkeratinocytes w ith UV radiation did 
no t alter spontaneous o r stimulated secretion ofLTs, whi le 
pretreatment of cell s w ith la, but not w ith T hy-l, mono-
clonal antibodies caused a moderate decrease of release. 
Analyses by HPLC indi cated the release of 20-0H-LTB4 
in addition to LTB4 in cell supernatants. Murine keratino-
cytes and epidermal dendritic cells serve therefore as a source 
of chemotactic leukotrienes after appropriate in vitro stim-
ulation with agents that are kn own to playa ro le in cu-
taneous inAammation. J filli es! Derll/a!o/ 87:489-493, 1986 
Investiga tions on hum an keratinocytes are hampered by the 
un ava ilability of larger quantities of skin and by ethical consid-
erations w ith rega rd to in vivo modulation of the cells. For this 
reason, we have decided to transfer our methods for inducing LT 
secretion from human keratinocytes [17,18) to the more read il y 
ava ilable murine model. In the present investiga tion we ptesen t 
data on the kinetics of release of chemotacti c L Ts fro m mo use 
epidermal cells, th e efficacy of various sti muli with potential in 
vivo releva nce o n L T secretion , and the abili ty of cells fro m 
different bod y reg ions to ca use L T release. In addition, the mod-
ul ation of release by chemi cals, by eliminatio n of dendritic cells, 
and by UV radiation was studied. T he data provide new insights 
into the potential contribu tion of epiderm al cells to inflammatory 
dermatoses. 
MATERIALS AND METHODS 
Preparation of Cells Murine epidermal cells were obtained 
fro m 6- to 8-week-old BA LBlc mice. T he isolation of cells from 
the ears and abdo men followed a seq uence of trypsinization , sep-
aration of epidermis from dermis with forceps, and gentle trea t-
ment w ith a Potter E lvehj em device to obtain single cell suspcn-
sions, as previously described for hum an cells [1 7, 18]. Epidermal 
cells from the central part of the ta il were rubbed off w ith a g lass 
rod after trypsiniza tion. T he cells were washed twice in RPMI 
med ium (Seromed, Munich, F.R. G.), coun ted, and differen-
tiated. There were never any cells other than epidermal cells in 
the preparatio ns, as determined by microscopic exa mination of 
cytocentrifuge preparations of the cells. Viability, as determined 
by eosin Y exclusion (Serva, Heidelberg, F. R.G.), ra nged be-
tween 70-80% for the tail keratinocytes and was generall y slig htl y 
lower fo r the Potter Elvehjem-treated ce ll ~. 
Mediator Release Cells wcre adjusted to 1 x 1 07 li ving cells/ ml 
RPMI and incubated fro m 10 min up to 18 h , 37°C, alone o r with 
one of the following reagents: AA (Sig ma , Munich, F.RG.), 
10 - 3-10- 5 M; the calcium ionophore A 23187 (Ion) (Eli Lilly, St. 
Louis , Missouri), at 10 - 5, 5 X 10 - 6, and 10- 6 M; co mbinations 
of both agents; N-form yl- methionyl-I cucyl-phenylalanine 
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Figure 1. Representative experiment, showing the kinetics of release of 
chemotactic activity from murine epidermal cells in the presence of AA 
and [on. No activity was found in supernatants of cells incubated in the 
presence of [on or buffer alone. Data are expressed as mean ± 1 SO of 
quadruplicate samples and as percent of the LTD. (10 - 8 M) standard 
(ordilwle). 
(NFMLP) from 10- '-10- 9 M, bradykinin from 2 X 10- 3-10 - 8 
M, and phorbol-myristate-acetate (PMA) from 10- 5_10- 8 (all from 
Sigma). Cell viability dropped to 0 after a 10-min stimulation 
with AA, 10- 3 M , while only a 50% decrease was noted with 
AA , 10- 4 M . The other stimuli had no effect on viability at the 
concentrations used. 
Modulation of Release In some experiments, cells were prein-
cubated for 10 min, 37°C, with the cyclooxygenase inhibitor 
indo methacin , 10- 6_10- 8 M , or with the lipoxygenase inhibitor 
nordih ydroguare ti c acid (NDGA), at 10- 4 and 10- 5 (both from 
Sigma) . 
A modulating effect of UVB on L T secretion was studied by 
irradiating mice with a UVB-Waldmann lamp (Sylvania bulbs, 
F7S/8SW, UV 6 + 21;UVA,0.SmW/cm2 , UVB2.4 mW/cm 2 , 
Waldmann , Villingen, Schwenningen, F.R.G.) . The dosage was 
15,000-30,000 J/m2 as a single dose, or 6000 J/ m 2 as a daily dose 
for 6 weeks . The keratinocytes were harvested immediately after 
the irradiation or 10 h later and were then stimu lated as noted 
above. Cells were also irradiated in vitro with 100- 400 J/m2 or 
with 500-1250 J/ m 2 immediately before stimulation. [n order to 
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clarify the exact source of L Ts, epidermal cell suspensions in 
RPMI with 10% feta l ca lf serum, were also pretreated with 
Thy-1 ala (from Becton Dick inson, Twickenham, U .K.) or a 
combination of both monoclonal antibodies at 1:100 dilution for 
30 min at 4°C. T he cells were then centrifuged and incubated 
with rabbit complement (Cedarlane, Hornby, Ontario, Canada) 
for 30 min , 37°C. Some cells were treated on ly with complement 
for control. Stimulation with AA 10 - '1 M fo llowed as described 
above. Cytocentrifuge preparations of Thy-l- and ala- trea ted cells 
were visualized with antimouse antibody and immunoperoxidase 
[18] . 
[n some experiments, cells were preincubated for 10 mi n, 37°C, 
with the receptor in hi bitor N-t-BOC-L-norleucyl-L-leucyl-L-
pheny lalanine (BOC) (Sigma) [19) at 10- " M and 10- 5 M prior 
to stimulation with NFMLP 10 - 7 M . 
Bioassays The in vitro chemotaxis assay was performed in 
modified Boyden chambers, with guinea pig eosinophils or hu-
man neutrophils as target cells, as prev iously described [20]. Re-
sul ts were expressed as percent of the standard L TB4, 10- 8 M 
(from Dr. E. J. Rokach, Montrea l, Canada). 
Reverse- Phase HPLC Analysis Cell supernatants were ex-
tracted 3 times into ether, pH 3.0, evaporated, resuspended in 
methanol:water at 69:31, pH 5.7, and eluted over a LiChrosorb 
RP 18 column (5 J.Lm) (Merck, Darmstadt: F.R.G .) with a Waters 
associated system (Milford , Massachusetts). The flow rate was 
0.5 ml/min. Fractions were evaporated, reconstituted in RPM! 
buffer, adjusted to pH 7.4, and assayed in the bioassay and the 
radioimmunoassay (RIA) . Prostaglandin (PG) B2 (Sigma) , LTB" 
(III) , 20-0H-L TB4, 20-COOH-L TB4 (from D r. E. J. Rokach, 
Montrea l, Canada) , 6,8 ,10-trans-S S,12 R-di-HETE (LTB4 I) , 
6,8, 10-trans-S S,12 S-di-HETE (L TB" 1/), 1S-HETE, and 12-
HETE (from Dr. G. Loschen , Aachen , F.R.G.) served as marker 
molecules . 
Radioimmunoassay Reagents for the L TB., RIA were pur-
chased from Well come, Darfort, England . The test was per-
form ed as previously described [18]. The antibody cross-reacts 
to a low degree with AA (0.005 and 0.03% ) and with mono-
HETEs (0 .07 and 2%, respectively) [21 and information of the 
manu facturer]. 
RESULTS 
Murine epidermal cell s responded to in vitro stimulation with the 
time-dependent release of chemotactic ac tivity. AA, at 10- 3 M 
and 10-" M, was about equall y as good a stimulus and was max-
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Figure 2. Kinetics of release of che-
motactic activi ty after stimulation with 
different molar concentrations of 
bradykinin (A) or NFMLP (B). Results 
are expressed as in Fig 1. A, Brady-
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Table I. Effect of Different Stimulati on on Leukotriene B4 
Release 
Reactants 
Mediun' 
Medium + AA, 10 - 3 M 
Cells + AA, 10- 3 M 
Cells + bradykinin, 10 - 3 M 
Cells + NFMLP, 10- 7 M 
Cells + PMA , 10- 5 M 
LTD. (ng/ml) 
0.89 
4.40 
16.00 
1. 52 
1.1 8 
0.92 
Representative data from 5 different experiments, showi ng the effcct of dine rcnt 
stimuli o n LTB" release fro m 111 urine epidermal cells ;lfter a 60-mi n incubation, as 
measured in the L TB, RIA. N o te the backg round activity due to llIediu lll and to 
AA, 10- 3 M . The other reagents did not cross-react in the fHA . 
imally effective after a to-min interaction with the cells. Longer 
stimulation yielded less activity (Fig 1) , and lower concentrations 
of AA were ineffective (not shown). Addition of the Ion at 5 X 
10-6 M enhanced the rel ease, but delayed th e peak activity in time 
(Fig 1). Low-level chemotactic activities were also measured on 
incu bation of cells with buffer alone or with the Ion. Levels that 
exceeded 10% of the optimal release in the presence of AA were 
reached only in 17% (8 of 48) of the experiments w ith th e Ion 
and in 5% (5 of95) of the experiments with cells in buffer alone. 
AA was more effective at 10- 3 M than at lower concentrati ons 
in 11 of 14 experiments . [n one half of the experim ents, optimal 
release w ith AA at to - 3 M occurred at 10 min, w hile in the 
remaining half, maxima were reached by 30 min . 
Fig 2 shows the kinetics of release of chemota ctic activity w ith 
2 other stimu li , bradykinin and NFMLP, at d ifferent molar con-
centrations. Bradykinin was most ac tive at 10- 3 M, w hile the 
optimal stimulation with NFMLP occurred at 10 - 7• T he kinetics 
of release were slower with NFMLP than w ith arachidonate o r 
bradykinin. At 100-fold concentrations of NFMLP, BOC re-
duced L TB4 secretion (RIA) by 50-60% over 60 min of stimu-
lation in 2 different experiments. PMA caused no release at all at 
the con centrations used for stimulation. 
. Table I shows a quanti tative comparison of the induction of 
L TB4 secretion by various stimuli , as measured in the LTB. RIA. 
AA was always th e most effecti ve stimulus, and PMA was 111-
effective . 
In 8 different experiments, the ability of epidermal cells to 
respond to in vitro stimulation was compared for cells from ears, 
abdomen, and tail of the mice. O ne such experiment is illustrated 
in Fig 3. While the tail epidermal cells seem superior to those of 
abdomen and ea r in the experiment shown, the reverse was true 
in o ther experiments, so that no cell source proved to be superior 
to the other. 
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Figure 3. [nfluencc of sourccs of epidermal cc lls from different regions 
of the body and modulation of AA-induced release of chemotactic activity 
from epidermal cells with time by the lipoxygcnase-inhibitor NDGA. 
Data are expressed as in Fig 1. Hatched bars = Ta il; solid bars = car; opell 
bars = abdomen. 
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Table II. Influence of Dendritic Cell s on Leukotriene 
Secretion from Epidermal Cells 
Chemotaxis LTB. R[A 
(% LTD." (nlean , Viability 
Reactants 10- " M) ng/ml) (%) 
B+C+B o ± 0" 0.24 52 
B + C + a3 68 ± II 4.60 50 
Thy- I + C + aa 148 ± 17 4.00 10 
ala + C + aa 27 ± 5 3. 10 54 
ala + Thy- I + C + aa 54 ±9 7.60 14 
Cells arc pretreated wi th butTer (5) alone or with Th y- l or la monoclonal anti-
bod ies. fo llowed by expos ure to complement (C) and 30-l11i n incubation with AA 
10- 7 M or buncr. A reduction of chemotactic and L T5, (RIA) activity in the su-
pcrn :tt:1I1[s was o nl y seen with :lla-trcatcd cells. 
' Mean ± I SO. 
N ord ihydroguareti c acid, at the concentrations used , blocked 
the release of chemotactic activity in all instances (see Fig 3), w hile 
indomethacin ca used an up to 20% increase of release in 5 of 11 
experiments (not shown) . 
Elimination of T hy-l + dendritic cells did not markedly affect 
the secretion of chem otactic L Ts, while removal of Langerhans 
cells reduced the act ivities in the epiderm al cell supernatants (Ta-
ble II ). After combined treatment w ith both antibodies, this effect 
was no longer evident. 
In vivo o r in vitro pretrea tm ent of keratinocytes w ith UVB 
did not cause changes in the spontaneous or stimulated production 
of chemotactic activity under any of the conditions studied (data 
not shown). . 
In order to further characterize the nature of the chem otactic 
activity released by epidermal cells, the cell supernatants were 
studied by reverse-p hase HPLC. T he supernatants of AA (10- 3 
M)-st in1Ulated cells yielded the typical 3-peak configuration for 
the LTB4 isomers at fractions 7 and 8 (Fig 4), w ith measurable 
biologic ac tivity onl y in fractions at the position for the isomer 
III of LTB.!. Some biologic activity was also found at the marker 
positions for 20-COOH-LTB4 and 20-0H-L TB4 • Other, uni-
dentified peaks were noted at the di-HETE and the mOllo-HETE 
regions, but chemotactic activity was no t found in the mono-
HETE region. AA alone, w hen eluted over the column, yielded 
no peaks at all . 
When NFMLP and bradykinin were used as stimulants (Fig 5), 
very similar elution curves were observed as with the AA-stim-
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Figure 4. Elution profile of AA-stimulated epidermal cell supernatan ts 
on reversc-phase HPLC. UV absorption was recorded at 280 nm for the 
morc polar di-HETEs and at 229 nm for the mono-HETEs. Positions of 
marker molecules are shown by arrol/iS. The chemotactic activity of the 
fractions is shown in the upper inset by shaded bars and is expressed as 
percent L TB, standard. 
492 M O LLER, SCHWANITZ , A N D CZARNET Z KI 
V1 
CD 
« 
> 
::::> 
NFMLP 
2lJOnm....-- 2 29nm 
15- HE rE 
I 
15 - HETE 
10 16 ,8 20 22 24 26 28 30 J2 
Bradykin in 
Figure 5_ Elution profi le of epidermal cell supernatants after stimulation 
with NFMLP or bradykinin . PGB2 had bcen added to the supern atants 
as an internal marker. The position of marker moleculcs fo r the different 
fractions (abscissa) is shown by arrows. 
ul ated cell supern atants. Examination of the eluates in the L TB4 
RIA demonstrated increased quantities of reactants at the L TB4 
position for bradykinin and at the 20-01--l-L TB4 position for 
NFMLP . T hey represented in each case 20% of the total amount 
measured in the supern atants. 
DISC USSION 
T he present paper provides a series o f data w hich suggest that 
intact murine epidermal cells can be induced to secrete chemo-
tactic L Ts in vitro. Evidence fo r this is based on : (1) the biologic 
activity, i.e., the chemotactic ability o f the reactant products in 
the cell supernatants; (2) the identift ca tionof L T s in the RIA for 
L T B4; (3) the inhibition o f secretory activity of the cells by the 
lipoxygenasc inhibitor NDGA and on the partial enhancement of 
secretion by indo methacin; and (4) the coelution of chemotacti c 
and RIA- reactive peaks with marker molecules of authentic L TB" 
and its 20-0 H- metabo lites. 
N one of the points listed provides sufficient evidence on its 
own to identify LT s w ith certainty: (1) A number of o ther me-
diato rs besides L Ts ca use leukocyte chemotaxis. (2) T he RIA 
cross-reacts with AA , w ith isom ers and with metabolites of the 
L Ts [21] . (3) NDGA inhibits the 5-lipoxygenase and thus the 
produ ction of a number of products that depend on this enzyme 
fo r generation [22], and the enhancement of L T production by 
the cyclooxygenase inhibitor indo methacin is no proof for lipox-
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ygenase activity either. (4) The coelution with marker molecul es 
on reverse-phase H PLC does not give any definite certainty abou t 
the chemi ca l configuration in the bioassay and the RIA . 
When all thi s evidence is taken together, there is, however , 
good reason to assume that murine epidermal cells are able to 
secrete LTs. The data ag ree also with a study on subcellular fra c-
tions of murine keratinocytes which could be induced to generate 
LTB4 11 61. 
One additional group o f workers has reported in 2 abstracts 
on the production o f L TB,,-like material from human keratino-
cytes [23,24). supporting our own findin gs with these sam e cells 
[17 ,18]. 
. Of the different stimuli that were used to induce L T secretio n 
the Ion was ineffective or weak, in agreement w ith data repo rted 
by Ziboh et 31 [25] and in contrast to findin gs with neutrophils 
where Ion is thought to activate both phos pholipase A2 and the 
5-lipoxygenase [26], mobilizing the exogenous AA sto res for the 
5-lipoxygenase to wo rk on . Additi on of AA to the keratinocy tes 
o vercomes the apparent defi ciency o f AA in the incubation mix-
tu re . In fa ct, AA alone is the mos t effective stimulus o f LT pro-
du ction amon g the reagents studi ed here, with a possible syn-
ergisti c effect after addition o f Ion (Fig 1) . Very high doses are 
cyto toxic, even though production of L Ts continues, in agree-
ment w ith the observation of Z iboh et al [1 6] on subcellular 
fractions o f murine keratin ocy tes. 
Two additio nal stimuli w hich indu ce L T secretion from intact 
murine epidermal cells are NFMLP and bradykinin . Neither of 
them is cyto toxic, but the release is slower and less marked (Fig 
2, T able 1) . Bo th stimuli are known to act as secretagogues of 
other types o f leukocytes . NFMLP ca uses LTB" secreti on fro m 
human neutrophils [1 2, 13). probably without activati on of the 
phos pho lipase A2 (26). resulting in the produ ction o f the w-OH-
metabolites of L TB" as well [1 2]. in agreement with our Ow n 
findin gs . Bradykinin causes histamine and AA release from mouse 
mast cells [27] at concentra tions similar to those which cause L T 
release fro m epiderm al cells , as reported here. Since L T s have an 
antagoni stic effect on bradykinin-induced hyperalgesia [28], the 
produ ction o f L T s by bradykinin may represent a regul atory 
mechanism of the acti on o f this mediator on nerves . 
PMA belongs to the group o f pho rbo l es ters that act as tumo r 
pro motors. These agents stimulate a variety of fun cti ons o f neu-
trophil s and macroph ages [29,30] and have been shown to ca use 
release o f PGs and AA from keratinocytes [31]. L TB" or L T C 4 
were not released from macrophages on exposure to phorbol 
esters [31], in conforman ce with our own observations. The re-
lease of AA or the activation o f the cyclooxygenase is therefore 
not necessa rily coupled with 5- lipoxygenase activation. One pos-
sible explanation for the lack o f L T production by keratin ocytes 
on exposure to phorbol esters may also relate to the fact that 
PMA prevents the use o f AA by the cell once it is released, as 
has been observed with neutrophil s [30] . 
Our o bservations that UV radiation did not induce o r modulate 
LT release from epiderm al cells under a grea t variety of circum-
stances, would furth er suppo rt the view that PG and L T release 
is not coupled, since UV radiation increased PGF2a and mOl1o-
.HETE levels, but not the amo unt o f L TB" in human skin [32]. 
Ho w this differential activation of the cyclooxygenase pathways 
o f AA metabolism is regulated , remains unex plained . 
E pidermal cell s in different body regions vary with regard to 
the contribution o f Langerhans cells and T hy-l + dentritic cells. 
Studies w ith cell suspensions from different body regions showed 
no consistent difference in the quality of LTs secreted after stim-
ul ation. Eliminati on of Langerhans cells w ith monoclonal fa an-
tibody and complement redu ced the qu antity o f chemotactic L Ts 
onl y to some extent so that one must assume that these cells 
contribute to the L T production of epidermal cells . This does not 
hold for Thy-1 '" cells, and secreti on of L T s from the remaining 
epiderm al cells seems to be even improved . 
In summary, murine epidermal cells ca n be used as a model to 
study in vitro release ofL T s from intact cell s in vitro. The process 
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is induced by certain specific stimuli, is not coupled to any se-
cretory process 0,[ to AA release from the cells, and does not 
necessarily requi re a living cell. Further studies of this system 
may provide additional insights into the pathology and phar-
macology of the skin . 
The at/thors wish to thallk Ms. A. Feldlllaml mId Ms. I . Wiil/elll l/eber for thei,. 
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